ABSTRACT
Aim: In this study, we aimed to investigate the effect of ozone therapy on pain, depression and quality of life in patients with fibromyalgia syndrome (FMS).
Materials and Method: A total of 70 female patients aged 18-65 who were diagnosed with FMS and received ozone therapy in addition to physiotherapy were included in the study. Demographic data such as age, gender, and clinical parameters such as Visual Analague Scalae(VAS), Beck Depression Index(BDI) and Fibromyalgia Impact Questionnaire(FIQ) were analyzed retrospectively. Patients were divided into two groups as the ozone and control groups. Patients in the control group were administered classical physical therapy (hotpack, TENS) for three weeks. Whereas, the major autohemotherapy method was applied in the ozone therapy group simultaneously with the classical physical therapy again for three weeks. Both groups were compared in terms of VAS for pain severity, BDI for depression, and FIQ for quality of life in before and after the treatment.
Results: There was no significant difference between age (36,68±2,84/35,85±3,77) (p:0,626) and body mass index (BMI) (23,78±2,41/23,65±2,70) (p:0,728) between the ozone and the control group respectively. Pain severity (p<0,001), depression (p<0,001) and quality of life (p<0,001) were significantly improved after treatment in both groups compared the before treatment, while better improvement was observed in the ozone group after treatment (p<0,001).
Conclusion: Our study demonstrated that ozone therapy has better effects on pain severity, depression and quality of life in patients with FMS. Therefore it can be added to treatment safely.